Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19

Detalhes bibliográficos
Autor(a) principal: Yıldız,Murat
Data de Publicação: 2021
Outros Autores: Aksu,Funda, Yıldız,Nurdan, Aksu,Kurtuluş
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista da Associação Médica Brasileira (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000200097
Resumo: SUMMARY OBJECTIVE: Failure to achieve high levels of medication adherence in obstructive lung diseases is a major cause of uncontrolled disease. The purpose of this study is to reveal clinicians’ opinions on the level of patient adherence and the change in adherence during the COVID-19 pandemic. METHODS: A questionnaire containing multiple-choice questions about treatment adherence in patients with obstructive lung diseases was voluntarily applied to doctors working in a tertiary hospital for chest diseases. RESULTS: Eighty-one doctors (mean age, 37.2 years [standard deviation, 9.7 years]; 57 (70.4%) women) answered the questionnaires. Almost all clinicians participating in the study reported that they always or frequently asked patients if they adhered to treatment. Most clinicians think that in 20–50% of patients with asthma and less than 20% of patients with chronic obstructive pulmonary disease, a decrease in medication adherence appears in the first year of treatment. Most clinicians think the main reason for patients with obstructive lung diseases not adhering is patients’ reluctance to be treated regularly. Regarding the impact of the COVID-19 pandemic on patients’ drug adherence, 43.2% of clinicians observed that adherence increased after the start of the pandemic. CONCLUSIONS: Adherence to medication is not at the desired levels in patients with obstructive lung diseases. However, when faced with a serious health threat, such as the COVID-19 pandemic, patients realize the severity of their illness and begin using their treatments more regularly.
id AMB-1_7e3d971d1fd9b2dacc78308f729f5c56
oai_identifier_str oai:scielo:S0104-42302021000200097
network_acronym_str AMB-1
network_name_str Revista da Associação Médica Brasileira (Online)
repository_id_str
spelling Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19AsthmaPulmonary diseasechronic obstructiveCoronavirus infectionsMedication adherenceSUMMARY OBJECTIVE: Failure to achieve high levels of medication adherence in obstructive lung diseases is a major cause of uncontrolled disease. The purpose of this study is to reveal clinicians’ opinions on the level of patient adherence and the change in adherence during the COVID-19 pandemic. METHODS: A questionnaire containing multiple-choice questions about treatment adherence in patients with obstructive lung diseases was voluntarily applied to doctors working in a tertiary hospital for chest diseases. RESULTS: Eighty-one doctors (mean age, 37.2 years [standard deviation, 9.7 years]; 57 (70.4%) women) answered the questionnaires. Almost all clinicians participating in the study reported that they always or frequently asked patients if they adhered to treatment. Most clinicians think that in 20–50% of patients with asthma and less than 20% of patients with chronic obstructive pulmonary disease, a decrease in medication adherence appears in the first year of treatment. Most clinicians think the main reason for patients with obstructive lung diseases not adhering is patients’ reluctance to be treated regularly. Regarding the impact of the COVID-19 pandemic on patients’ drug adherence, 43.2% of clinicians observed that adherence increased after the start of the pandemic. CONCLUSIONS: Adherence to medication is not at the desired levels in patients with obstructive lung diseases. However, when faced with a serious health threat, such as the COVID-19 pandemic, patients realize the severity of their illness and begin using their treatments more regularly.Associação Médica Brasileira2021-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000200097Revista da Associação Médica Brasileira v.67 suppl.1 2021reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.67.suppl1.20201095info:eu-repo/semantics/openAccessYıldız,MuratAksu,FundaYıldız,NurdanAksu,Kurtuluşeng2021-08-19T00:00:00Zoai:scielo:S0104-42302021000200097Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2021-08-19T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false
dc.title.none.fl_str_mv Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19
title Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19
spellingShingle Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19
Yıldız,Murat
Asthma
Pulmonary disease
chronic obstructive
Coronavirus infections
Medication adherence
title_short Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19
title_full Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19
title_fullStr Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19
title_full_unstemmed Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19
title_sort Clinician’s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19
author Yıldız,Murat
author_facet Yıldız,Murat
Aksu,Funda
Yıldız,Nurdan
Aksu,Kurtuluş
author_role author
author2 Aksu,Funda
Yıldız,Nurdan
Aksu,Kurtuluş
author2_role author
author
author
dc.contributor.author.fl_str_mv Yıldız,Murat
Aksu,Funda
Yıldız,Nurdan
Aksu,Kurtuluş
dc.subject.por.fl_str_mv Asthma
Pulmonary disease
chronic obstructive
Coronavirus infections
Medication adherence
topic Asthma
Pulmonary disease
chronic obstructive
Coronavirus infections
Medication adherence
description SUMMARY OBJECTIVE: Failure to achieve high levels of medication adherence in obstructive lung diseases is a major cause of uncontrolled disease. The purpose of this study is to reveal clinicians’ opinions on the level of patient adherence and the change in adherence during the COVID-19 pandemic. METHODS: A questionnaire containing multiple-choice questions about treatment adherence in patients with obstructive lung diseases was voluntarily applied to doctors working in a tertiary hospital for chest diseases. RESULTS: Eighty-one doctors (mean age, 37.2 years [standard deviation, 9.7 years]; 57 (70.4%) women) answered the questionnaires. Almost all clinicians participating in the study reported that they always or frequently asked patients if they adhered to treatment. Most clinicians think that in 20–50% of patients with asthma and less than 20% of patients with chronic obstructive pulmonary disease, a decrease in medication adherence appears in the first year of treatment. Most clinicians think the main reason for patients with obstructive lung diseases not adhering is patients’ reluctance to be treated regularly. Regarding the impact of the COVID-19 pandemic on patients’ drug adherence, 43.2% of clinicians observed that adherence increased after the start of the pandemic. CONCLUSIONS: Adherence to medication is not at the desired levels in patients with obstructive lung diseases. However, when faced with a serious health threat, such as the COVID-19 pandemic, patients realize the severity of their illness and begin using their treatments more regularly.
publishDate 2021
dc.date.none.fl_str_mv 2021-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000200097
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000200097
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1806-9282.67.suppl1.20201095
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Médica Brasileira
publisher.none.fl_str_mv Associação Médica Brasileira
dc.source.none.fl_str_mv Revista da Associação Médica Brasileira v.67 suppl.1 2021
reponame:Revista da Associação Médica Brasileira (Online)
instname:Associação Médica Brasileira (AMB)
instacron:AMB
instname_str Associação Médica Brasileira (AMB)
instacron_str AMB
institution AMB
reponame_str Revista da Associação Médica Brasileira (Online)
collection Revista da Associação Médica Brasileira (Online)
repository.name.fl_str_mv Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)
repository.mail.fl_str_mv ||ramb@amb.org.br
_version_ 1754212835998564352